SILK News and Press, Silk Road Medical Inc. From 12/20/23

SUNNYVALE, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced the company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference. Manageme...

SAN FRANCISCO, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Hagens Berman encourages Silk Road Medical, Inc. (NASDAQ: SILK) investors who suffered substantial losses to submit your losses now . Hagens Berman is investigating potential violations of the securities laws. Visit: www.h...

Silk Road Medical, Inc (NASDAQ: SILK) is one of today's top gainers. The company's shares have moved 7.13% on the day to $7.21. Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease cal...

2023-11-09 00:37:08 ET Silk Road Medical, Inc (SILK) Q3 2023 Earnings Conference Call November 8, 2023, 4:30 PM ET Company Participants Marissa Bych - Gilmartin Group, Director, Investor Relations Jack Lasersohn - Chairman Chas McKhann - Chief Executive Officer ...

2023-11-08 16:37:39 ET Silk Road Medical press release ( NASDAQ: SILK ): Q3 GAAP EPS of $0.33 beats by $0.67 . Revenue of $44.4M (+18.7% Y/Y) beats by $0.06M . Projects revenue for full year 2023 to range from $170 million to $174 million. For further det...

SUNNYVALE, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three months ended September 30, 2023. “As announced on November 2, we ar...

Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...

Silk Road Medical Inc. (SILK) is expected to report $-0.36 for Q3 2023

2023-11-02 08:40:30 ET More on Silk Road Medical Silk Road Medical: Unsure On Economics Given List Of Probabilities (Rating Downgrade) Silk Road Medical CEO Erica Rogers to step down Seeking Alpha’s Quant Rating on Silk Road Medical For further details...

SUNNYVALE, Calif., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road” or the “Company”), a company focused on reducing the risk of stroke and its devastating impact, today announced that Chas McKhann has been appointed Chief Exec...